2023 Guidelines Update Eligibility for Lung Cancer Screening
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 9, 2023 -- In a guideline update issued by the American Cancer Society and published online Nov. 1 in CA: A Cancer Journal for Clinicians, the authors recommend increasing eligibility for lung cancer screening (LCS).
Andrew M.D. Wolf, M.D., from the University of Virginia School of Medicine in Charlottesville, and colleagues updated the American Cancer Society 2013 LCS guidelines for adults at high risk for lung cancer.
The Guideline Development Group judged that the evidence was moderate and sufficient to support a strong recommendation for screening those who meet eligibility criteria. In men and women aged 50 to 80 years, LCS is associated with a reduction in lung cancer deaths; inferential evidence supports screening for those older than 80 years in good health. For asymptomatic individuals aged 50 to 80 years, annual LCS with low-dose computed tomography is recommended for those who currently smoke or formerly smoked and have a ≥20 pack‐year smoking history. Individuals should engage in a shared decision-making discussion with a qualified health professional before the decision is made to initiate LCS. The number of years since quitting smoking is not an eligibility criterion for screening initiation or cessation among individuals who formerly smoked. Screening should not be undertaken by individuals with comorbid conditions that substantially limit life expectancy.
"This updated guideline continues a trend of expanding eligibility for lung cancer screening in a way that will result in many more deaths prevented by expanding the eligibility criteria for screening to detect lung cancer early," lead author Robert Smith, M.D., from the American Cancer Society, said in a statement.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.